Project Grant R35GM158317

Award Date 8/1/25
Completion Date 5/31/30
Dollars Obligated $382K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
This federal Project Grant award of $413,690 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports research to delineate the neuronal circuits and signaling pathways that regulate developmental timing in response to social cues in the model organism C. elegans. The research aims to identify how the nervous system non-autonomously regulates organismal growth and development, with the potential to alter...
This $565,826 Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training Program (CFDA 93.859), supports research at Duke University to elucidate the signaling and gene regulatory mechanisms that enable nematodes (C. elegans) to adapt to fluctuations in nutrient availability. The research aims to identify novel components, regulatory interactions, and effector mechanisms in the conserved network of tumor suppressors...
This $393,093 federal Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) will support a research program to uncover the interplay between gene expression, cell morphology, and tissue-level mechanics in embryonic development. The research aims to develop an integrative computational framework to analyze spatio-temporal data on gene expression, cell morphometrics, and tissue mechanics...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under CFDA 93.859 - Biomedical Research and Research Training program provides $627,797 to Cornell University from May 1, 2025 to April 30, 2030. The goal of the research is to delineate the mechanisms connecting endocytic and junctional complexes with epithelial pathology in C. elegans. The project leverages a multi-disciplinary approach combining genetic screens, live imaging, biochemical assays, and...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) provides $180,500.00 to investigate the genetic regulation of sperm activation in the nematode C. elegans. The project aims to understand the molecular mechanisms by which phosphatases regulate this process, as well as identify additional genetic regulators of sperm development and function. The research will leverage unique...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $508,315 to the University of California, San Diego (UCSD) to uncover the molecular mechanisms required for successful developmental progression from oocyte to embryo during the window of transcriptional silence in mammals. The overarching goal is to improve understanding of the earliest stages of mammalian development and the...
This federal Project Grant award of $651,596 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports research by the Cold Spring Harbor Laboratory (CSHL) to study the molecular mechanisms that coordinate gene expression, cell fate determination, and tissue growth during development. The key research objectives are to: 1) Determine the molecular structures and dynamics of three transcriptional complexes that regulate...
The National Institute of General Medical Sciences (NIGMS) awarded a $324,239 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to Ora Biomedical, Inc., a biotechnology company in Seattle, WA. The purpose of this Phase I Small Business Innovation Research (SBIR) grant is to develop "ELEGANTRY", a software and hardware infrastructure to improve rigor and reproducibility in invertebrate research using the model organism Caenorhabditis elegans (C....
This National Science Foundation (NSF) Biological Sciences (CFDA 47.074) Project Grant award of $1,000,000 to the University of Michigan provides funding from August 1, 2024 to July 31, 2028 to study the molecular mechanism of telomere maintenance in the model organism Caenorhabditis elegans. The research aims to leverage the simplicity of the worm's shelterin protein complex to answer fundamental questions about the structure and function of these proteins in chromosome end protection and...
This $198,724 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) supports research to understand the functional genetic basis of the Wolbachia-Drosophila endosymbiosis. The research project, led by the University of California, Santa Cruz, aims to reveal the microevolutionary processes driving host and symbiont evolution, the developmental processes enabling symbionts to induce their own...

This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) provides $381,801 to the University of California, Santa Cruz to conduct research on developmental timers and the apical extracellular matrix in the nematode C. elegans. The award supports three interconnected projects: 1) determining how biological timers control development, 2) testing whether a specific nuclear hormone receptor is ligand-regulated to control molting, and 3) investigating how the apical extracellular matrix is formed and remodeled during development, with a focus on protease and protease inhibitor regulation. This research aims to provide insights into fundamental biological processes with potential applications for understanding human development and combating parasitic nematode infections. The award period runs from August 1, 2025 to May 31, 2030.

Generated 7/1/25, 2:44 AM